2008 Press Releases
2007 Press Releases
2006 Press Releases
2005 Press Releases
Investor Events Calendar
December 11, 2007
ChemGenex Investigators Report Omacetaxine Effective in Killing CML Stem Cells in Animal Model Studies
December 10, 2007
ChemGenex Investigators Report Activity of Omacetaxine in Imatinib-Resistant Chronic Myeloid Leukemia Patients with the T315I Mutation
December 06, 2007
ChemGenex Appoints Donald Santel to Board of Directors
December 04, 2007
ChemGenex Announces Poster Presentations at the 49th Annual Meeting of the American Society of Hematology
November 29, 2007
ChemGenex Announces Shareholder Approval to Demerge Verva Pharmaceuticals
October 30, 2007
ChemGenex Pharmaceuticals to Present at Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference
October 29, 2007
ChemGenex Announces Strategic Restructuring of Company to Focus on Late-Stage Cancer Portfolio
October 08, 2007
ChemGenex Appoints Experienced Biotechnology Executive as Chief Medical Officer
October 01, 2007
ChemGenex Announces Positive Preliminary Data from Phase 2/3 Clinical Trial of Ceflatonin
®
at International Conference
September 24, 2007
ChemGenex Announces Second Publication Demonstrating Activity of Ceflatonin
®
in T315I-Positive Chronic Myeloid Leukemia
August 06, 2007
ChemGenex to Present at Canaccord Adams’ 27th Global Growth Conference
June 12, 2007
ChemGenex Announces Publication Confirming Activity of Ceflatonin
®
in T315I-Positive CML
June 04, 2007
ChemGenex Reports Successful Personalized Dosing of Quinamed
®
at ASCO
May 30, 2007
ChemGenex Appoints Dr George Morstyn to Board of Directors
May 21, 2007
Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML
April 17, 2007
ChemGenex Reports Preclinical Data at American Association of Cancer Research (AACR) Annual Conference
April 04, 2007
ChemGenex Announces Initiation of Second Phase 2/3 Clinical Trial for Ceflatonin® in CML
April 03, 2007
ChemGenex Announces the Completion of A$21 Million Financing
February 14, 2007
Clinical Data Supporting Development of ChemGenex’s Ceflatonin® Published in Cancer
February 13, 2007
ChemGenex Announces Appointment of Two Experienced Non-Executive Directors
February 08, 2007
ChemGenex Announces New Significant Investors, Completes Capital Raising, Announces Rights Issue and Board Changes
February 01, 2007
ChemGenex Announces Granted U.S. Patent For Ceflatonin® Manufacturing
© 2005 ChemGenex Pharmaceuticals |
Terms of Use
